S-PEDITE

Serial Number 79337934
Registration 6966222
700

Registration Progress

Application Filed
Jan 25, 2022
Under Examination
Approved for Publication
Nov 15, 2022
Published for Opposition
Nov 15, 2022
Registered
Jan 31, 2023

Trademark Image

S-PEDITE

Basic Information

Serial Number
79337934
Registration Number
6966222
Filing Date
January 25, 2022
Registration Date
January 31, 2023
Published for Opposition
November 15, 2022
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 31, 2023
Registration
Registered
Classes
040 042

Rights Holder

Samsung Biologics Co., Ltd.

03
Address
300, Songdo bio-daero,
Yeonsu-gu Incheon
KR

Ownership History

Samsung Biologics Co., Ltd.

Original Applicant
03
KR

Samsung Biologics Co., Ltd.

Owner at Publication
03
KR

Samsung Biologics Co., Ltd.

Original Registrant
03
KR

Legal Representation

Attorney
Brian P. Gregg

USPTO Deadlines

Next Deadline
1283 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-01-31)
Due Date
January 31, 2029
Grace Period Ends
July 31, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

22 events
Date Code Type Description Documents
May 30, 2023 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
May 8, 2023 FIMP P FINAL DISPOSITION PROCESSED Loading...
May 8, 2023 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Apr 30, 2023 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jan 31, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 31, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Nov 15, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 15, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 26, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 11, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 5, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 5, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 5, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 31, 2022 RFNT P REFUSAL PROCESSED BY IB Loading...
May 6, 2022 RFRR P REFUSAL PROCESSED BY MPU Loading...
May 6, 2022 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Apr 28, 2022 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Apr 27, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 22, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 19, 2022 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 15, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 14, 2022 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 040
Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials; generation of cell line for the manufacture of biopharmaceutical materials, namely, biomanufacturing for others in the nature of biopharmaceuticals using biological organisms in the manufacturing process; chemical treatment of liquids; custom manufacturing services in the nature of processing of medicinal materials; custom manufacture of pharmaceuticals; processing of pharmaceutical preparations; preservation of pharmaceuticals; processing of medical products; processing of chemicals
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
Medical research in the field of crude drugs; development of cell therapy products; development of pharmaceutical preparations and medicines; drug development; inspection of pharmaceuticals; research of pharmaceuticals; scientific research in the nature of conducting clinical testing of medicine for others; pharmaceutical products evaluation; research of medical product; bacteriological research and analysis; medical laboratory services; stem cell research services; conducting clinical trials for others; medicine research; research and development of technology for biotechnology; microbial culture trials, namely, conducting clinical trials for others; biochemistry research services; genetic research for scientific purposes; scientific research in the field of genetic engineering
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
040 042